Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMCS.L Share News (MCS)

  • There is currently no data for MCS

Wednesday broker round-up

Wed, 15th Jul 2020 12:24
(Sharecast News) - Royal Dutch Shell: JP Morgan downgrades to neutral with a target price of 1,700.0p.



Ocado Group: Berenberg reiterates buy with a target price of 2,225.0p.

DFS: Berenberg reiterates buy with a target price of 210.0p.

Atalaya Mining: Canaccord reiterates buy with a target price of 220.0p.

McCarthy & Stone: Canaccord reiterates hold with a target price of 82.0p.

Ferrexpo: JP Morgan downgrades to underweight with a target price of 150.0p.

GlaxoSmithKline: Citigroup reiterates neutral.

Auto Trader Group: Deutsche Bank reiterates buy with a target price of 680.0p.

London Stock Exchange: Deutsche Bank reiterates hold with a target price of 7,700.0p.

Legal & General Group: Deutsche Bank reiterates buy with a target price of 290.0p.

Senior: Barclays reiterates underweight with a target price of 45.0p.

Marks & Spencer Group: Barclays reiterates overweight with a target price of 140.0p.

Fevertree Drinks: Liberum reiterates buy with a target price of 2,570.0p.

Big Yellow Group: Liberum reiterates hold with a target price of 1,000.0p.

Dunelm Group: Peel Hunt reiterates buy with a target price of 1,400.0p.

Related News

GSK, Hansoh's targeted cancer drug hits main survival goal in China trial
1 day ago

GSK, Hansoh's targeted cancer drug hits main survival goal in China trial

* GSK partner Hansoh reports first late-stage data ​for experimental ⁠lung cancer drug

GSK says Ris-Rez meets primary endpoint in phase 3 lung cancer trial
1 day ago

GSK says Ris-Rez meets primary endpoint in phase 3 lung cancer trial

(Alliance News) - GSK PLC on Friday announced that risvutatug rezetecan has delivered "meaningful" survival data in a "pivotal" trial for advanced or ...

GSK hails 'milestone' drug trial results in China
2 days ago

GSK hails 'milestone' drug trial results in China

(Sharecast News) - A targeted lung cancer treatment developed by GSK has shown promising results in the latest trials in China, the pharma blue chip c...

MCS.L News

UK BROKER RATINGS SUMMARY: Barclays Initiates Housebuilder Ratings
9 Oct 2020

UK BROKER RATINGS SUMMARY: Barclays Initiates Housebuilder Ratings

UK BROKER RATINGS SUMMARY: Barclays Initiates Housebuilder Ratings

McCarthy & Stone Partners With Non-Profit For Later Life Housing
1 Oct 2020

McCarthy & Stone Partners With Non-Profit For Later Life Housing

McCarthy & Stone Partners With Non-Profit For Later Life Housing

Wednesday broker round-up
15 Jul 2020

Wednesday broker round-up

(Sharecast News) - Royal Dutch Shell: JP Morgan downgrades to neutral with a target price of 1,700.0p.

McCarthy & Stone Swings To First Half Loss, Suspends Dividend
15 Jul 2020

McCarthy & Stone Swings To First Half Loss, Suspends Dividend

McCarthy & Stone Swings To First Half Loss, Suspends Dividend

McCarthy & Stone swings to loss because of Covid-19
15 Jul 2020

McCarthy & Stone swings to loss because of Covid-19

(Sharecast News) - McCarthy & Stone said the impact of Covid-19 would be weighted towards the second half of the year as lower sales during the cr...

Wednesday preview: Covid-19 vaccines, Burberry in focus
14 Jul 2020

Wednesday preview: Covid-19 vaccines, Burberry in focus

(Sharecast News) - The focus in markets is likely to be on the news-flow around potential Covid-19 vaccines following confirmation that a third phase ...

UK Earnings, Trading Statements Calendar - Next 7 Days
8 Jul 2020

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

TOP NEWS: Centrica And easyJet Bumped From FTSE 100 For Avast And GVC
3 Jun 2020

TOP NEWS: Centrica And easyJet Bumped From FTSE 100 For Avast And GVC

TOP NEWS: Centrica And easyJet Bumped From FTSE 100 For Avast And GVC